Primary Cicatricial Alopecia: Recent Advances in Understanding and Management

    November 2011 in “ The Journal of Dermatology ”
    Manabu Ohyama
    Image of study
    TLDR New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.
    The document from 2011 reviews the pathogenesis and management of primary cicatricial alopecia (PCA), highlighting the importance of accurate diagnosis using dermoscopy, a new pathological preparation technique, and direct immunofluorescence. It discusses the role of bulge stem cells, lipid metabolism dysregulation, and various other factors in PCA development. Novel therapeutic approaches, such as PPAR-y agonists, are proposed based on the understanding of these mechanisms. The document also emphasizes the potential of high-throughput screening methods for understanding PCA and developing treatments, while acknowledging the challenges in diagnosis and treatment. It does not provide specific numbers of people involved in studies, focusing instead on molecular and clinical research advancements.
    Discuss this study in the Community →

    Research cited in this study

    26 / 26 results

    Related Community Posts Join

    6 / 282 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  136 upvotes 7 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  121 upvotes 5 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

    Related Research

    10 / 10 results